With one in five Americans developing skin cancer by age 70, it has become one of the most prevalent forms of cancer globally. While skin cancer is highly treatable at early stages, delays in identification substantially increase risk. Effective assessment of patients with potential skin cancer in primary care settings is vital. Innovative technologies like DermaSensor® have emerged as cutting-edge preventative cancer screening tools that will help with early detection and diagnosis.
DermaSensor is an advanced diagnostic tool designed to analyze suspicious-looking skin lesions with high precision and accuracy. The ability to analyze microscopic lesions helps identify potentially malignant growths at their earliest stages. This is good news for Chicagoland business professionals who take their physical health seriously because checking for skin cancer and early skin cancer detection, in addition to health screenings, are directly linked to significantly better treatment outcomes and improved longevity.
Read on to learn more about this skin cancer-detecting technology and where to find the best primary doctor that uses DermaSensor in Chicago.
How DermaSensor Works
DermaSensor utilizes a light-based technology known as Elastic Scattering Spectroscopy (ESS) alongside their FDA-approved artificial intelligence (AI) algorithm to analyze suspicious skin lesions and provide accurate assessments of their potential malignancy — in other words, whether or not they could be cancerous. The device’s specialized sensors capture high-resolution images of the skin's surface.
DermaSensor’s tip reflects and records quick bursts of light off a skin lesion’s cellular and subcellular structures to provide comparable information to biopsy assessments. This approach is based on findings from the literature that show that malignant lesions exhibit different cellular structures than benign lesions, scattering light differently. The DermaSensor device uses its AI algorithm to evaluate the likelihood of malignancy, specifically focusing on the following:
- Basal cell carcinoma, the most popular type of skin cancer
- Squamous cell carcinoma, the next most common type of skin cancer
- Melanoma, the third most common but deadliest type of skin cancer
By examining differences in light scattering down to the cellular level, the DermaSensor obtains information even beyond the routine criteria, such as asymmetry, border irregularity, color variation, and diameter — commonly known as the ABCD criteria for skin malignancy detection. The AI-driven analysis enhances the accuracy of the diagnosis, significantly reduces the likelihood of unnecessary skin biopsy, and enables a Chicago DermaSensor physician to provide prompt insight into skin health.
This is a major advantage for busy Chicago professionals who are looking for an effective and efficient way to get a skin cancer check without taking a lot of time out of their day. However, it's essential to remember that the DermaSensor does not replace an annual skin check; if any malignancy is detected or suspected, you’ll be referred to a dermatologist for further evaluation and care.
What Are the Benefits of DermaSensor?
Powered by FDA-breakthrough technology, DermaSensor delivers a state-of-the-art solution for accurate skin cancer detection. Designed with efficiency in mind, one of the primary advantages is its ability to provide rapid, objective assessments of skin lesions without compromising quality.
The integration of advanced imaging technology and artificial intelligence also gives primary care doctors in Chicago a way for more informed decision-making. Its rapid results can minimize physician and patient referral time, creating a ripple effect that benefits the healthcare ecosystem. This efficiency streamlines the patient care process and alleviates anxiety for patients awaiting cancer screening results in Chicago.
Skin Cancer Types That DermaSensor Can Detect
DermaSensor is designed to detect a variety of skin cancer types — specifically, melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC). Melanoma, known for its aggressive nature and potential to metastasize, is a key target for early detection, as prompt intervention can significantly improve survival.
In addition to melanoma, DermaSensor effectively identifies basal cell carcinoma, which is the most prevalent form of skin cancer — often manifesting as pearly or waxy bumps on the skin. The system also aids in detecting squamous cell carcinoma, which may appear as firm, red nodules or scaly patches.
Any new or changing spots could be a sign of skin cancer and should be taken seriously. Those who have a family medical history of cancer need to be especially vigilant.
By employing FDA-approved advanced spectral imaging and AI-driven analysis, DermaSensor enhances skin cancer detection and empowers concierge doctors in Chicago to implement appropriate medical care by providing objective, actionable results based on information that cannot be seen visually — ultimately reducing the risk of skin cancer progression and improving patient prognosis.
Where to Find a Doctor Who Uses DermaSensor in Chicago
SHIFT concierge medicine in Chicago offers a revolutionary approach to healthcare by combining personalized care with cutting-edge technology focused on optimizing your healthspan and lifespan. Our comprehensive executive physicals in Chicago include access to the innovative DermaSensor skin cancer screening tool — making SHIFT the only healthcare provider in the Chicagoland area to offer this advanced technology. This integration of advanced screening methods combined with our personalized healthcare approach sets SHIFT apart in improving your overall health, longevity, and performance.
Our unique combination of concierge healthcare and innovative tools, like DermaSensor, empowers our Members to prioritize their health while excelling in their professional lives. By choosing SHIFT, you gain access to unparalleled medical expertise and technology, ensuring proactive care that aligns with your demanding lifestyle.